Solvents and Parkinson disease: A systematic review of toxicological and epidemiological evidence
Authors:
- 1 February 2013
- journal article
- review article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 266 (3) , 345-355
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicityNeuroToxicology, 2012
- Industrial toxicants and Parkinson's diseaseNeuroToxicology, 2012
- Traumatic brain injury and trichloroethylene exposure interact and produce functional, histological, and mitochondrial deficitsExperimental Neurology, 2012
- Solvent exposures and parkinson disease risk in twinsAnnals of Neurology, 2011
- Occupational exposure in Parkinsonian disorders: A 43-year prospective cohort study in menParkinsonism & Related Disorders, 2011
- Occupational factors and risk of Parkinson's disease: A population‐based case–control studyAmerican Journal of Industrial Medicine, 2009
- The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathwayProceedings of the National Academy of Sciences, 2009
- Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyteProceedings of the National Academy of Sciences, 2009
- DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidaseProceedings of the National Academy of Sciences, 2007
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991